In the fight against cancer, researchers are turning to innovative ways to strengthen the immune system’s response to cancer cells. Recently, 3D biomaterial scaffolds are being incorporated into cancer vaccines. Read on here for more…
Researchers at Stanford University injected two substances into cancerous tumours in mice to eliminate the injected tumour and others of the same cancer type in different parts of the body. The injection also stops cancer from spreading in the body and prevents future tumours that might arise due to genetic conditions. Read this review of the study to learn about the promising results and to understand the key concepts of immunotherapy used in this novel cancer treatment.
Here we interview Gregg Sando, founder of Cell Medica and Dr. Martin Pule , founder of Autolus. Both recently spoke at the SIULondon event ‘Advances in Immunotherapy’. Read here to find out more about their career journeys into commercialization of immunotherapies and what they see for the future of this field.
The new frontier of the fight against diseases such as cancer is genetic engineering of immune system cells to be better equipped to target disregulated cells. SIULondon recently hosted speakers from Cell Medica, Autolus, GSK and Cell & Gene Therapy Catapult to cover research advances in the field of immunotherapy, hurdles to bringing this treatment to the bedside and regulatory challenges. Check out the event summary here…
Ahead of the SIULondon ‘Advances in Immunotherapy’ event, we interviewed Dr. Bo Kara from GlaxoSmithKline (GSK) and Dr. Jacqueline Barry from Cell and Gene Therapy (CGT) Catapult. Both experts share their role in supporting the cell and gene therapy field and give their insights on industry science and more… Read on here.
The promising developments in immunotherapy in recent years catch the attention of not only patients and researchers but also investors. In this article we bring you the latest financial trends in immunotherapy investments.
Cancer is a disease that affects a substantial portion of the world population. Cancer immunotherapy is one of the latest methods to target the disease and it has gained a lot of momentum lately because of its potential as an effective therapy. In this article we describe what cancer immunotherapy means, the latest developments in the field and what we should expect from it in the near future.